-

Kaskela Law LLC Announces Shareholder Investigation of Driven Brands Holdings, Inc. (NASDAQ: DRVN) and Encourages Long-Term DRVN Shareholders to Contact the Firm

PHILADELPHIA--(BUSINESS WIRE)--Kaskela Law LLC announces that it is investigating Driven Brands Holdings Inc. (NASDAQ: DRVN) (“Driven”) on behalf of the company’s long-term investors.

https://kaskelalaw.com/case/driven-brands-holdings/

Recently a securities fraud complaint was filed against Driven on behalf of investors who purchased shares of the company’s stock between October 27, 2021 and August 1, 2023. According to the complaint, during that time period Driven and certain of the company’s senior executive officers made a series of materially false and misleading statements, and omitted to disclose material adverse information, concerning the Company’s two most important growth initiatives: (i) the creation of a nationwide auto-glass business by rapidly acquiring and integrating smaller companies into a single “platform,” and (ii) operational execution and customer retention in the Company’s critical car wash business. Specifically, the defendants are alleged to have “repeatedly assured investors that the Company was executing on both of these key growth strategies and, as such, reaffirmed highly positive earnings growth projections.”

As detailed in the complaint, on August 2, 2023, Driven was forced to slash its guidance by an astonishing 24% and admit that, far from making “significant progress” in integrating its auto-glass network, the company’s integration was actually “several quarters behind” and, as a result, the Company would have to shrink the scope of its auto-glass network by a third. In addition, Driven finally disclosed substantially declining same store car wash sales driven by “significant competitive . . . growth.” Indeed, just a few weeks later, Driven would write-down its car wash segment by nearly $1 billion, equal to more than 10% of Driven’s entire asset value as of the end of 2022.

Following this news, shares of Driven’s stock fell $10.63 per share, or over 41% in value, to close on August 2, 2023 at $15.20 per share, on unusually heavy trading volume.

The investigation seeks to determine whether the members of Driven’s board of directors violated the securities laws and/or breached their fiduciary duties in connection with the above alleged misconduct.

Driven shareholders who purchased or acquired their currently held shares of DRVN stock prior to August 1, 2023 are encouraged to contact Kaskela Law LLC (D. Seamus Kaskela, Esq. or Adrienne Bell, Esq.) at (484) 229 – 0750 for additional information about this investigation and their legal rights and options. Alternatively, investors may submit their information to the firm by clicking on the following link (or by copying and pasting the link into your browser):

https://kaskelalaw.com/case/driven-brands-holdings/

Kaskela Law LLC exclusively represents investors in securities fraud, corporate governance, and merger & acquisition litigation on a contingent basis. For additional information about Kaskela Law LLC please visit www.kaskelalaw.com.

This notice may constitute attorney advertising in certain jurisdictions.

Contacts

KASKELA LAW LLC
D. Seamus Kaskela, Esq.
(skaskela@kaskelalaw.com)
Adrienne Bell, Esq.
(abell@kaskelalaw.com)
18 Campus Blvd., Suite 100
Newtown Square, PA 19073
(888) 715 – 1740
(484) 229 – 0750
www.kaskelalaw.com

Kaskela Law LLC

NASDAQ:DRVN

Release Versions

Contacts

KASKELA LAW LLC
D. Seamus Kaskela, Esq.
(skaskela@kaskelalaw.com)
Adrienne Bell, Esq.
(abell@kaskelalaw.com)
18 Campus Blvd., Suite 100
Newtown Square, PA 19073
(888) 715 – 1740
(484) 229 – 0750
www.kaskelalaw.com

More News From Kaskela Law LLC

Kaskela Law LLC Announces Investigation of Amneal Pharmaceuticals, Inc. (AMRX) and Encourages AMRX Shareholders to Contact the Firm

PHILADELPHIA--(BUSINESS WIRE)--Kaskela Law is investigating Amneal Pharmaceuticals, Inc. (Nasdaq: AMRX) (“Amneal”) on behalf of the company’s current shareholders. The investigation seeks to determine whether Amneal or the company’s officers and/or directors violated the securities laws or breached their fiduciary duties in connection with recent corporate actions. Amneal shareholders are encouraged to contact Kaskela Law LLC (D. Seamus Kaskela, Esq. or Adrienne Bell, Esq.) for additional infor...

Kaskela Law Firm Announces Investigation of DexCom, Inc. (DXCM) and Encourages Long-Term DXCM Shareholders with Investment Losses to Contact the Firm

PHILADELPHIA--(BUSINESS WIRE)--Investor litigation firm Kaskela Law announces that it is investigating DexCom, Inc. (Nasdaq: DXCM) on behalf of the company’s long-term investors. Click here for additional information: https://kaskelalaw.com/case/dexcom-inc/ Recently a securities fraud complaint was filed against DexCom on behalf of investors who purchased shares of the company's stock between January 8, 2024 and September 17, 2025 (the “Wrongdoing Period”). According to the complaint, during th...

Kaskela Law Firm Announces Investigation of Fortrea Holdings Inc. (FTRE) and Encourages Long-Term FTRE Shareholders with Investment Losses to Contact the Firm

PHILADELPHIA--(BUSINESS WIRE)--Investor litigation firm Kaskela Law announces that it is investigating Fortrea Holdings Inc. (Nasdaq: FTRE) (“Fortrea”) on behalf of the company’s long-term investors. Click here for additional information: https://kaskelalaw.com/case/fortrea-holdings/ Recently a securities fraud complaint was filed against Fortrea on behalf of certain investors who purchased shares of the company’s stock between July 5, 2023 and February 28, 2025 (the “Wrongdoing Period”). Accor...
Back to Newsroom